These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10582170)

  • 1. Experimental approaches to the development of a recombinant hookworm vaccine.
    Hotez PJ; Ghosh K; Hawdon JM; Narasimhan S; Jones B; Shuhua X; Sen L; Bin Z; Haechou X; Hainan R; Heng W; Koski RA
    Immunol Rev; 1999 Oct; 171():163-71. PubMed ID: 10582170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hookworm vaccines.
    Diemert DJ; Bethony JM; Hotez PJ
    Clin Infect Dis; 2008 Jan; 46(2):282-8. PubMed ID: 18171264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A history of hookworm vaccine development.
    Schneider B; Jariwala AR; Periago MV; Gazzinelli MF; Bose SN; Hotez PJ; Diemert DJ; Bethony JM
    Hum Vaccin; 2011 Nov; 7(11):1234-44. PubMed ID: 22064562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths.
    Diemert DJ; Pinto AG; Freire J; Jariwala A; Santiago H; Hamilton RG; Periago MV; Loukas A; Tribolet L; Mulvenna J; Correa-Oliveira R; Hotez PJ; Bethony JM
    J Allergy Clin Immunol; 2012 Jul; 130(1):169-76.e6. PubMed ID: 22633322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hookworm burden reductions in BALB/c mice vaccinated with recombinant Ancylostoma secreted proteins (ASPs) from Ancylostoma duodenale, Ancylostoma caninum and Necator americanus.
    Sen L; Ghosh K; Bin Z; Qiang S; Thompson MG; Hawdon JM; Koski RA; Shuhua X; Hotez PJ
    Vaccine; 2000 Jan; 18(11-12):1096-102. PubMed ID: 10590331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular approaches to vaccinating against hookworm disease.
    Hotez PJ; Hawdon JM; Cappello M; Jones BF; Ghosh K; Volvovitz F; Xiao SH
    Pediatr Res; 1996 Oct; 40(4):515-21. PubMed ID: 8888276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative.
    Hotez PJ; Zhan B; Bethony JM; Loukas A; Williamson A; Goud GN; Hawdon JM; Dobardzic A; Dobardzic R; Ghosh K; Bottazzi ME; Mendez S; Zook B; Wang Y; Liu S; Essiet-Gibson I; Chung-Debose S; Xiao S; Knox D; Meagher M; Inan M; Correa-Oliveira R; Vilk P; Shepherd HR; Brandt W; Russell PK
    Int J Parasitol; 2003 Sep; 33(11):1245-58. PubMed ID: 13678639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-dependent reductions in mouse hookworm burden after vaccination with Ancylostoma caninum secreted protein 1.
    Ghosh K; Hotez PJ
    J Infect Dis; 1999 Nov; 180(5):1674-81. PubMed ID: 10515831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum.
    Mendez S; Zhan B; Goud G; Ghosh K; Dobardzic A; Wu W; Liu S; Deumic V; Dobardzic R; Liu Y; Bethony J; Hotez PJ
    Vaccine; 2005 May; 23(24):3123-30. PubMed ID: 15837211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus.
    Xiao S; Zhan B; Xue J; Goud GN; Loukas A; Liu Y; Williamson A; Liu S; Deumic V; Hotez P
    Exp Parasitol; 2008 Jan; 118(1):32-40. PubMed ID: 17645877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray structure of Na-ASP-2, a pathogenesis-related-1 protein from the nematode parasite, Necator americanus, and a vaccine antigen for human hookworm infection.
    Asojo OA; Goud G; Dhar K; Loukas A; Zhan B; Deumic V; Liu S; Borgstahl GE; Hotez PJ
    J Mol Biol; 2005 Feb; 346(3):801-14. PubMed ID: 15713464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunobiology of hookworm infection.
    Loukas A; Constant SL; Bethony JM
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):115-24. PubMed ID: 15681140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74.
    Pearson MS; Jariwala AR; Abbenante G; Plieskatt J; Wilson D; Bottazzi ME; Hotez PJ; Keegan B; Bethony JM; Loukas A
    Hum Vaccin Immunother; 2015; 11(5):1251-7. PubMed ID: 26018444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with alum-precipitated recombinant Ancylostoma-secreted protein 1 protects mice against challenge infections with infective hookworm (Ancylostoma caninum) larvae.
    Ghosh K; Hawdon J; Hotez P
    J Infect Dis; 1996 Dec; 174(6):1380-3. PubMed ID: 8940240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hookworm infections in human and laboratory animals--differences and similarities in immune responses.
    Długosz E
    Wiad Parazytol; 2005; 51(3):219-25. PubMed ID: 16913526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals.
    Bethony J; Loukas A; Smout M; Brooker S; Mendez S; Plieskatt J; Goud G; Bottazzi ME; Zhan B; Wang Y; Williamson A; Lustigman S; Correa-Oliveira R; Xiao S; Hotez PJ
    FASEB J; 2005 Oct; 19(12):1743-5. PubMed ID: 16037096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults.
    Bethony JM; Simon G; Diemert DJ; Parenti D; Desrosiers A; Schuck S; Fujiwara R; Santiago H; Hotez PJ
    Vaccine; 2008 May; 26(19):2408-17. PubMed ID: 18396361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunoepidemiology of human hookworm infection.
    Quinnell RJ; Bethony J; Pritchard DI
    Parasite Immunol; 2004; 26(11-12):443-54. PubMed ID: 15771680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of hookworm calreticulin as a potential vaccine for necatoriasis.
    Winter JA; Davies OR; Brown AP; Garnett MC; Stolnik S; Pritchard DI
    Parasite Immunol; 2005 Apr; 27(4):139-46. PubMed ID: 15910422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency testing for the experimental Na-GST-1 hookworm vaccine.
    Jariwala AR; Oliveira LM; Diemert DJ; Keegan B; Plieskatt JL; Periago MV; Bottazzi ME; Hotez PJ; Bethony JM
    Expert Rev Vaccines; 2010 Oct; 9(10):1219-30. PubMed ID: 20923271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.